Novartis AG
SIX:NOVN

Watchlist Manager

Novartis AG

SIX:NOVN

Watchlist

Dividends

Price: 93.68 CHF 2.32% Market Closed

Market Cap: 189.7B CHF

Have any thoughts about
Novartis AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 93.68 CHF

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NOVN Alert

Novartis AG

93.68

+2.12 (+2.32%)

52 Week Range	80.9944 102.7
Price Target

We'll email you a reminder when the closing price reaches CHF.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Novartis AG

What unique competitive advantages
does Novartis AG hold over its rivals?

What risks and challenges
does Novartis AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Novartis AG.

What unique competitive advantages
does Novartis AG hold over its rivals?

What risks and challenges
does Novartis AG face in the near future?

Has there been any significant insider trading activity
in Novartis AG recently?

Summarize the latest earnings call
of Novartis AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novartis AG.

Provide P/S
for Novartis AG.

Provide P/E
for Novartis AG.

Provide P/OCF
for Novartis AG.

Provide P/FCFE
for Novartis AG.

Provide P/B
for Novartis AG.

Provide EV/S
for Novartis AG.

Provide EV/GP
for Novartis AG.

Provide EV/EBITDA
for Novartis AG.

Provide EV/EBIT
for Novartis AG.

Provide EV/OCF
for Novartis AG.

Provide EV/FCFF
for Novartis AG.

Provide EV/IC
for Novartis AG.

Show me price targets
for Novartis AG made by professional analysts.

What are the Revenue projections
for Novartis AG?

How accurate were the past Revenue estimates
for Novartis AG?

What are the Net Income projections
for Novartis AG?

How accurate were the past Net Income estimates
for Novartis AG?

What are the EPS projections
for Novartis AG?

How accurate were the past EPS estimates
for Novartis AG?

What are the EBIT projections
for Novartis AG?

How accurate were the past EBIT estimates
for Novartis AG?

Compare the revenue forecasts
for Novartis AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novartis AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novartis AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novartis AG compared to its peers.

Compare the P/E ratios
of Novartis AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Novartis AG with its peers.

Analyze the financial leverage
of Novartis AG compared to its main competitors.

Show all profitability ratios
for Novartis AG.

Provide ROE
for Novartis AG.

Provide ROA
for Novartis AG.

Provide ROIC
for Novartis AG.

Provide ROCE
for Novartis AG.

Provide Gross Margin
for Novartis AG.

Provide Operating Margin
for Novartis AG.

Provide Net Margin
for Novartis AG.

Provide FCF Margin
for Novartis AG.

Show all solvency ratios
for Novartis AG.

Provide D/E Ratio
for Novartis AG.

Provide D/A Ratio
for Novartis AG.

Provide Interest Coverage Ratio
for Novartis AG.

Provide Altman Z-Score Ratio
for Novartis AG.

Provide Quick Ratio
for Novartis AG.

Provide Current Ratio
for Novartis AG.

Provide Cash Ratio
for Novartis AG.

What is the historical Revenue growth
over the last 5 years for Novartis AG?

What is the historical Net Income growth
over the last 5 years for Novartis AG?

What is the current Free Cash Flow
of Novartis AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novartis AG.

EV/EBITDA
Enterprise Value to EBITDA

10.1

Current

9.4

Median

13.3

Industry

Higher than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

10.1

Enterprise Value

191.4B CHF

EBITDA

21.3B USD

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
CH		Novartis AG SIX:NOVN	183.3B CHF	10.1
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 459 134.4
US		Eli Lilly and Co NYSE:LLY	710.5B USD	45.7
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	3 846.3
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	24.3
US		Johnson & Johnson NYSE:JNJ	373.5B USD	12.3
US		Merck & Co Inc NYSE:MRK	251.1B USD	10.5
CH		Roche Holding AG SIX:ROG	202.7B CHF	9.9
UK		AstraZeneca PLC LSE:AZN	162.4B GBP	169.4
IE	E	Endo International PLC LSE:0Y5F	146B USD	234.4
US		Pfizer Inc NYSE:PFE	145.4B USD	10.3

				EBITDA Growth
CH		Novartis AG SIX:NOVN	Average EV/EBITDA: 437.3 10.1	8%
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 459 134.4	N/A
US		Eli Lilly and Co NYSE:LLY	45.7	195%
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	151%
DK		Novo Nordisk A/S CSE:NOVO B	24.3	84%
US		Johnson & Johnson NYSE:JNJ	12.3	14%
US		Merck & Co Inc NYSE:MRK	10.5	331%
CH		Roche Holding AG SIX:ROG	9.9	23%
UK		AstraZeneca PLC LSE:AZN	169.4	64%
IE	E	Endo International PLC LSE:0Y5F	234.4	N/A
US		Pfizer Inc NYSE:PFE	10.3	31%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

10.5

2-Years Forward

EV/EBITDA

9.8

3-Years Forward

EV/EBITDA

9.5

Novartis AG
SIX:NOVN

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Novartis AG SIX:NOVN

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Novartis AG
SIX:NOVN

EV/EBITDA
Enterprise Value to EBITDA